Christophe Bancel

Founder at

Tissium SA

Health Technology

Finance

Profile

Christophe Bancel is the founder of iBionext SAS, founded in 2012, serving as Venture Partner since 2012.
Mr. Bancel is the founder of Tissium SA, founded in 2013, serving as Chief Executive Officer & Director since 2013.
Former job includes Director at BrainEver SAS.

Christophe Bancel active positions

Companies	Position	Start
Tissium SA Tissium SA BiotechnologyHealth Technology Develops biomorphic and programmable polymers for tissue reconstruction	Founder	01/01/2013
iBionext SAS iBionext SAS Investment ManagersFinance iBionext is an active manager invests in young companies located in France. The firm targets companies operating in the health technology (biotech/medtech/e-health). They provide equity financing for seed, later and growth capital requirements.	Founder	01/10/2012

All active positions of Christophe Bancel

Former positions of Christophe Bancel

Companies	Position	End
Brainever SAS Brainever SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapies for patients	Director/Board Member	-

See the detail of Christophe Bancel's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christophe Bancel's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Tissium SA Tissium SA BiotechnologyHealth Technology Develops biomorphic and programmable polymers for tissue reconstruction	Health Technology
iBionext SAS iBionext SAS Investment ManagersFinance iBionext is an active manager invests in young companies located in France. The firm targets companies operating in the health technology (biotech/medtech/e-health). They provide equity financing for seed, later and growth capital requirements.	Finance
Brainever SAS Brainever SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapies for patients	Health Technology